Gowling WLG advised Sosei Heptares on a multi-million pound drug with Boehringer Ingleheim.Sosei Heptares, a leading biopharmaceutical company, has joined forces with Boehringer Ingelheim in a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
